Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
86 hedge funds and large institutions have $26.8M invested in Tetraphase Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 22
7% less funds holding
Funds holding: 92 → 86 (-6)
30% less call options, than puts
Call options by funds: $26K | Put options by funds: $37K
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
58% less capital invested
Capital invested by funds: $63.4M → $26.8M (-$36.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$3.04M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.79M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$840K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$657K |
| 5 |
Two Sigma Investments
New York
|
+$540K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.24M |
| 2 |
BlackRock
New York
|
-$950K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$927K |
| 4 |
Millennium Management
New York
|
-$882K |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$690K |
TTPH Hedge Fund Activity: Q4 2018 in Review
86 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q4 2018, worth a combined $26.8M — down 58% from $63.4M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of TTPH and 8 opened new positions — a net loss of 6 holders — while 22 trimmed existing stakes and 32 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.04M. The largest seller was Vanguard Group, cutting an estimated $2.24M.
- 86 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q4 2018, down from 92 in Q3 2018.
- Funds reported $26.8M of Tetraphase Pharmaceuticals, Inc. stock for Q4 2018, down 58% quarter-over-quarter.
- 8 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q4 2018 and 14 closed out, a net change of -6 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q4 2018 was Renaissance Technologies, an estimated $3.04M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q4 2018 was Vanguard Group, an estimated $2.24M sold.
Based on aggregated 13F filings for Q4 2018.